Diagnomics offers high quality innovative R&D and CLIA services to global pharmaceutical, biotech, and medical device companies as well as academic institutions. Diagnomics provides comprehensive consumer genomics solutions based on several platforms including but not limited to DNA microarrays, Next Generation Sequencing and real-time PCR. We strive to deliver confidence and reliability by offering comprehensive genetic solutions for the development of personalized healthcare and precision medicine in the genomic market.
Our strength comes from a highly qualified team of scientists including early pioneers in sequencing the human genome. We have cutting edge genome presentation software as well as genome discovery expertise to guide the development of novel diagnostic tools and new therapeutic targets.